Target intelligence / Profile preview

Thermonuclease (Nuc1) (Nuc1)

Target
Nuc1
Molecular classification
Enzyme
01

Overview

Thermonuclease, commonly referred to as Nuc1 or micrococcal nuclease, is a major extracellular enzyme and critical virulence factor secreted by Staphylococcus aureus [6, 12]. Its primary biological function is the non-specific hydrolysis of both DNA and RNA into mono- and oligonucleotides [9, 10]. In the host environment, Nuc1 facilitates immune evasion by degrading the DNA backbone of neutrophil extracellular traps (NETs), which are web-like structures deployed by the host to entrap and kill pathogens [6, 21]. By destroying these traps, Nuc1 enables the bacterium to escape host killing and contributes to the persistence and dissemination of the infection [9, 10]. Additionally, Nuc1 plays a role in the modulation of biofilm formation and dispersal by regulating the levels of extracellular DNA (eDNA) within the biofilm matrix [8, 14]. From a therapeutic perspective, Nuc1 is an attractive anti-virulence target. Inhibition of its production or activity can disarm the bacteria and enhance host clearance without the selective pressure of traditional bactericidal antibiotics [6, 10]. Clinical agents such as clindamycin have been shown to downregulate nuc1 transcription at sub-inhibitory concentrations, while intravenous immunoglobulin (IVIG) contains neutralizing antibodies that can directly inhibit the enzyme's activity [6, 10]. Furthermore, the high conservation of the nuc gene across S. aureus strains makes it a definitive biomarker for rapid molecular diagnosis in clinical settings [1, 18].

Other names
Staphylococcal nucleaseMicrococcal nucleaseSNaseThermostable nucleasenuc gene productNuclease A
02

Mechanism of action

Inhibition of thermonuclease expression or enzymatic activity prevents the degradation of host-derived neutrophil extracellular traps (NETs), thereby restoring the ability of the innate immune system to entrap and clear the bacterial pathogen.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Potential for development of bacterial resistanceLimited efficacy against nuclease-deficient staphylococcal strains
06

Interacting drugs

Clindamycin

1 more in the full profile.

07

Biomarkers

Thermonuclease activitynuc1 mRNA expression levels

Beyond the preview

Go deeper on Thermonuclease (Nuc1) (Nuc1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thermonuclease (Nuc1) (Nuc1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call